Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
7.46M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
3.46M
-
Shares change
-
+1.34M
-
Total reported value, excl. options
-
$24M
-
Value change
-
+$9.35M
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$6.94
Significant Holders of KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) as of Q4 2024
31 filings reported holding KALA - KALA BIO, Inc. - Common Stock, $0.001 par value per share as of Q4 2024.
KALA BIO, Inc. - Common Stock, $0.001 par value per share (KALA) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.46M shares
of 7.46M outstanding shares and own 46.41% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (1.2M shares), Cormorant Asset Management, LP (603K shares), SR One Capital Management, LP (599K shares), SILVERARC CAPITAL MANAGEMENT, LLC (231K shares), ADAR1 Capital Management, LLC (220K shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (179K shares), MILLENNIUM MANAGEMENT LLC (136K shares), AIGH Capital Management LLC (121K shares), VANGUARD GROUP INC (53.6K shares), and GEODE CAPITAL MANAGEMENT, LLC (47.6K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.